Table 1.
Cost/treatment (US$) | Antidote * | Asia-Pacific Countries with annual per capita health expenditure in this range. |
---|---|---|
>$10 | Sodium Bicarbonate | Afghanistan, Laos |
$10-20 | Activated charcoal in suspension. | Bangladesh, Indonesia, |
Naloxone | Nepal, Pakistan | |
$20-50 | Atropine (low dose) | Cambodia, China, India,Papua New Guinea,Mongolia, Philippines, SriLanka, Vietnam |
$50-200 | Atropine (high dose) | Fiji, Malaysia, Maldives, |
Pyridoxine | Myanmar, Samoa, Thailand, | |
Succimer | Tonga | |
Cyclophosphamide/Methyprednisolone | ||
Flumazenil | ||
Acetylcysteine | ||
$200-1000 | Pralidoxime (low dose) | Singapore, South Korea |
Desferroxamine | ||
Hydroxocobalamin | ||
>$1000 | Digoxin binding Fab antibodies, | Australia, New Zealand, |
Pralidoxime (high dose) | Japan |
based on dose required in one severe adult poisoning - Australian Wholesale prices-December 2004